KaliVir Immunotherapeutics

KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells

Industries

Pharmaceutical

Headquarters

Pittsburgh, United States

Stage

Series A

Employees

51-200

Links

Org chart

Helena Chaye

Chief Executive Officer

Collapse

Stephen H. Thorne

Chief Scientific Officer

James M. Burke

Chief Medical Officer

Adina Pelusio

Senior Vice President, Clinical Operations

Kevin Chrestay

Intellectual Property Manager

Kurt Rote

Board Member, Founder

RAVIKUMAR MUTHUSWAMY

Director of Immunology

Suad Diglisic

Senior Manager Quality Control

Teams

View all

Board of Directors

12 members

CEO and Executive Team

3 members

Leadership Team

3 members

Discover similar companies

Walgreens Boots Alliance

Deerfield, United States

Eli Lilly

Indianapolis, United States · Series E

Omnicell

Mountain View, United States

Alnylam Pharmaceuticals

Cambridge, United States · Post IPO Equity

Bristol-Myers Squibb

Lawrence Township, United States

AbbVie

North Chicago, United States · Series B

SteriPack Contract Manufacturing

Lakeland, United States · Grant

Prescient Healthcare Group

Jersey City, United States · Private Equity

Viatris

Pittsburgh, United States

Nano Hearing Aids

Phoenix, United States

Karyopharm Therapeutics

Newton, United States · Post IPO Equity

Catalent

Franklin Township, United States · Venture

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.